Oliver S. Chow

2.6k total citations · 1 hit paper
26 papers, 1.2k citations indexed

About

Oliver S. Chow is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Oliver S. Chow has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Oliver S. Chow's work include Colorectal Cancer Surgical Treatments (10 papers), Colorectal Cancer Screening and Detection (9 papers) and Colorectal and Anal Carcinomas (9 papers). Oliver S. Chow is often cited by papers focused on Colorectal Cancer Surgical Treatments (10 papers), Colorectal Cancer Screening and Detection (9 papers) and Colorectal and Anal Carcinomas (9 papers). Oliver S. Chow collaborates with scholars based in United States, Italy and United Kingdom. Oliver S. Chow's co-authors include Julio García‐Aguilar, Karin Avila, Jorge Marcet, Samuel Oommen, Peter A. Cataldo, J. Joshua Smith, Martin R. Weiser, Garrett M. Nash, Sujata Patil and Marc J. Gollub and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Neuroscience.

In The Last Decade

Oliver S. Chow

25 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial

2015 436 citations Julio García‐Aguilar, Oliver S. Chow et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Oliver S. Chow

Since Specialization

Citations

This map shows the geographic impact of Oliver S. Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver S. Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver S. Chow more than expected).

Fields of papers citing papers by Oliver S. Chow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver S. Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver S. Chow. The network helps show where Oliver S. Chow may publish in the future.

Co-authorship network of co-authors of Oliver S. Chow

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver S. Chow. A scholar is included among the top collaborators of Oliver S. Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver S. Chow. Oliver S. Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cell lung cancer 2025 ·European Journal of Cardio-Thoracic Surgery ·(unknown), Abu Nasar, Jonathan Villena‐Vargas, S. Harrison, Benjamin Lee, Jeffrey L. Port, Nasser K. Altorki, Oliver S. Chow	0
2	Wedge resection, segmentectomy, and lobectomy: oncologic outcomes based on extent of surgical resection for ≤2 cm stage IA non-small cell lung cancer 2024 ·Journal of Thoracic Disease ·(unknown), Abu Nasar, Jonathan Villena‐Vargas, S. Harrison, Benjamin Lee, Jeffrey L. Port, Nasser K. Altorki, Oliver S. Chow	2
3	Epidemiological Study of Adenoid Cystic Carcinoma and Its Outcomes: Insights from the Surveillance, Epidemiology, and End Results (SEER) Database 2024 ·Cancers ·Mohamed Rahouma, (unknown), Massimo Baudo, (unknown), (unknown), (unknown), Abdelrahman Mohamed, Arnaldo Dimagli, (unknown), Mona Kamal, Jonathan Villena‐Vargas, Oliver S. Chow	2
4	Should sampling of three N2 stations be a quality metric for curative resection of stage I lung cancer? 2023 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), Abu Nasar, Jonathan Villena‐Vargas, Oliver S. Chow, Benjamin C. Lee, Jeffrey L. Port, Nasser K. Altorki, S. Harrison	4
5	Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non–small cell lung cancer: Results from a randomized trial 2022 ·Journal of Thoracic and Cardiovascular Surgery ·Benjamin Lee, (unknown), Abu Nasar, Jonathan Villena‐Vargas, Oliver S. Chow, S. Harrison, Brendon M. Stiles, Jeffrey L. Port, Nasser K. Altorki	11
6	Extent of Resection Influences Survival in Early-Stage Lung Cancer With Occult Nodal Disease 2022 ·The Annals of Thoracic Surgery ·(unknown), Abu Nasar, Mohamed Rahouma, Benjamin Lee, S. Harrison, Oliver S. Chow, Jonathan Villena‐Vargas, Nasser K. Altorki, Jeffrey L. Port	9
7	Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report 2021 ·Clinical Lung Cancer ·(unknown), Ashish Saxena, (unknown), Jeffrey L. Port, Benjamin E. Lee, S. Harrison, Oliver S. Chow, Jonathan Villena‐Vargas, Ronald Scheff, Giuseppe Giaccone, Nasser K. Altorki	16
8	P37.04 EGFR Mutations in US Hispanics with Lung Adenocarcinoma are Common and Portend a Worse Prognosis 2021 ·Journal of Thoracic Oncology ·Jonathan Villena‐Vargas, (unknown), Francesca Voza, Abu Nasar, Oliver S. Chow, (unknown), S. Harrison, Brendon M. Stiles, (unknown), Nasser K. Altorki	3
9	Outcomes After Surgical Resection of Early-stage Lung Adenocarcinomas With Epidermal Growth Factor Receptor Mutations 2021 ·The Annals of Thoracic Surgery ·Oliver S. Chow, Jonathan Villena‐Vargas, Abu Nasar, (unknown), S. Harrison, Benjamin C. Lee, Jeffrey L. Port, Nasser K. Altorki, Brendon M. Stiles	5
10	Characterizing Ischaemic Tolerance in Rat Pheochromocytoma (PC12) Cells and Primary Rat Neurons 2020 ·Neuroscience ·Ayesha Singh, Oliver S. Chow, Stuart I. Jenkins, Lingling Zhu, (unknown), (unknown), Ruoli Chen	4
11	Early Infant Symptomatic Patients With Tetralogy of Fallot With Absent Pulmonary Valve: Pulmonary Artery Management and Airway Stabilization 2020 ·The Annals of Thoracic Surgery ·Oliver S. Chow, David M. Hoganson, Aditya K. Kaza, Mariana Chávez, (unknown), Gerald R. Marx, Kevin G. Friedman, Russell W. Jennings, Christopher W. Baird	2
12	Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After Chemoradiation 2019 ·Journal of Gastrointestinal Surgery ·Oliver S. Chow, Sujata Patil, Metin Keskin, J. Joshua Smith, Maria Widmar, David Smith, Karin Avila, Jinru Shia, Peiguo Chu, Julio García‐Aguilar	2
13	Anorectal Function and Quality of Life in Patients With Early Stage Rectal Cancer Treated With Chemoradiation and Local Excision 2017 ·Diseases of the Colon & Rectum ·Patricio B. Lynn, Lindsay A. Renfro, Xiomara W. Carrero, Qian Shi, Paul Strombom, Oliver S. Chow, Julio García‐Aguilar	18
14	Single Nucleotide Polymorphism TGFβ1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients 2016 ·International Journal of Radiation OncologyBiologyPhysics ·J. Joshua Smith, Isaac Wasserman, Sarah A. Milgrom, Oliver S. Chow, Chin‐Tung Chen, Sujata Patil, Karyn A. Goodman, Julio García‐Aguilar	9
15	KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy 2016 ·Annals of Surgical Oncology ·Oliver S. Chow, Deborah Kuk, Metin Keskin, J. Joshua Smith, Niedzica Camacho, Raphael Pelossof, Chin‐Tung Chen, Zhenbin Chen, Karin Avila, Martin R. Weiser, Michael F. Berger, (unknown), Emily K. Bergsland, Julio García‐Aguilar	71
16	Integrated genomic profiling identifies microRNA‐92a regulation of IQGAP2 in locally advanced rectal cancer 2016 ·Genes Chromosomes and Cancer ·Raphael Pelossof, Oliver S. Chow, Lauren Fairchild, J. Joshua Smith, Manu Setty, Chin‐Tung Chen, Zhenbin Chen, (unknown), Karin Avila, Christina S. Leslie, Julio García‐Aguilar	8
17	Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial breakdown → 2015 ·The Lancet Oncology ·Julio García‐Aguilar, Oliver S. Chow, David Smith, Jorge Marcet, Peter A. Cataldo, Madhulika G. Varma, Anjali S. Kumar, Samuel Oommen, Theodore Coutsoftides, Steven R. Hunt, Michael J. Stamos, Charles A. Ternent, Daniel O. Herzig, Alessandro Fichera, Blasé N. Polite, David W. Dietz, Sujata Patil, Karin Avila	436
18	Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management 2015 ·BMC Cancer ·J. Joshua Smith, Oliver S. Chow, Marc J. Gollub, Garrett M. Nash, Larissa K. Temple, Martin R. Weiser, José G. Guillem, Philip B. Paty, Karin Avila, Julio García‐Aguilar	233
19	Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial 2015 ·The Lancet Oncology ·Julio García‐Aguilar, Lindsay A. Renfro, Oliver S. Chow, Qian Shi, Xiomara W. Carrero, Patricio B. Lynn, Charles R. Thomas, Emily Chan, Peter A. Cataldo, Jorge Marcet, David Medich, Craig S. Johnson, Samuel Oommen, Bruce G. Wolff, Alessio Pigazzi, Shane McNevin, (unknown), Ronald Bleday	256
20	KRAS mutation in colorectal cancer and its association with a stromal-derived gene signature. 2015 ·Journal of Clinical Oncology ·Raphael Pelossof, Moshe Elkabets, Oliver S. Chow, Lauren Fairchild, Chin‐Tung Chen, Manu Setty, J. Joshua Smith, Lukas E. Dow, Kevin P. O’Rourke, Scott W. Lowe, Christina S. Leslie, Julio García‐Aguilar	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact